Kong joined Sanofi China in 2010 as Head of Asia Pacific R&D and Legal Affairs, and was responsible for managing legal matters regarding to Sanofi’s daily operations in China and providing legal support to the Asia Pacific R&D Center, covering early research, preclinical studies, clinical trials, manufacturing, distribution, promotion, licensing, M&A, as well as innovative business models such as digital healthcare. Kong was responsible for a number of collaborative projects between Sanofi China and renowned external partner, including local companies, medical institutions, academic associations and patient groups. He led Sanofi’s first License-Out project in China, completed the closure and transfer of a Sanofi subsidiary’s research center in Beijing, assisted in the acquisition of local pharma companies and business integrations, participated as one of the main contributors in forming and negotiating Sanofi China’s first mobile healthcare project, and drafting relevant legal documents.

Prior to joining Hui Ye Law Firm, Kong practiced at Zhong Lun Law Firm and Shi Hui Partners, providing legal services to many domestic and foreign clients in various legal matters.

Kong currently also serves as the member of the standing committee of Chinese Society of Microcirculation for Transformation of Medicine and the leader of its Translational Medicine Working Group, and the member of the Ethics Committee of Guangzhou National Laboratory.

Andrea has been living in China since 2014 and joined Zunarelli Law Firm in 2017. He is Coordinator of the Healthcare Department at Zunarelli Group – Health Law Asia, and he is Managing Partner of Health Law Asia.

He graduated LL.M. in Law at the Catholic University of Milan in 2001, and he was admitted to the Milan Bar Association in 2004. From the very beginning of his professional career, Andrea has specialized in healthcare law, advising National Health Service institutions, private hospitals, pharmaceutical companies, medical device manufacturers, and global cosmetics brands.
His expertise focuses on competition and compliance, market access, and international trade of regulated healthcare products, as well as international cooperation in the healthcare sector.
Andrea provides legal and regulatory advice to European and Chinese companies, as well as to public and private institutions engaged in commercial or institutional cross-border relationships. He also represents European healthcare institutions in cooperation projects with Chinese government bodies and hospitals.

Andrea is a member of the editorial committee of the Pharmaceutical and Healthcare Law Journal and a member of the Healthcare Working Group of the China-Italy Chamber of Commerce (CICC).
As part of his academic background, Andrea published numerous papers and conducted seminars on healthcare law. He previously served as Assistant Professor of Administrative Law at the Catholic University of Milan.

Ivy Yang is Regional General Counsel of Asia Pacific at Bobst, one of the world's leading suppliers of substrate processing, printing and converting equipment and services for the label, flexible packaging, folding carton and corrugated board industries. She oversees the commercial legal department for all brands and divisions of Bobst Group in the APAC region, covering China, Hong Kong, Japan, Korea, Southeast Asia and Australia.  Her role spans a broad spectrum of corporate work including regulatory and internal investigations, restructuring and M&A, corporate governance, and commercial contracts. In the past three years, Ivy has served as a board member and general secretary of SwissCham Shanghai, along leading legal and compliance committee.